CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cognito Therapeutics, a neurotechnology company advancing disease-modifying therapies to treat CNS diseases, today announced the publication of a study in ...

Forbes contributors publish independent expert analyses and insights. I’m an analyst covering neurotech's impact on business and society. Cognito Therapeutics and West Virginia University’s ...

At the core of this initiative is Spectris™, Cognito’s investigational, non-invasive neuroprotective device designed for at-home use. Spectris™ has shown early promise in preserving brain structure ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cognito Therapeutics, a pioneering neurotechnology company developing disease-modifying therapies for neurodegenerative diseases, today announced key executive ...

The process of brain cell fusion has been recently implicated in the progression of central nervous system (CNS) viral diseases. This novel biological understanding has opened up a new field of ...